TALK vs. INNV, WGS, DCGO, SHCR, PNTG, PIII, USPH, TSHA, FATE, and ANL
Should you be buying Talkspace stock or one of its competitors? The main competitors of Talkspace include InnovAge (INNV), GeneDx (WGS), DocGo (DCGO), Sharecare (SHCR), The Pennant Group (PNTG), P3 Health Partners (PIII), U.S. Physical Therapy (USPH), Taysha Gene Therapies (TSHA), Fate Therapeutics (FATE), and Adlai Nortye (ANL). These companies are all part of the "medical" sector.
InnovAge (NASDAQ:INNV) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment, dividends and community ranking.
InnovAge has a net margin of -4.16% compared to InnovAge's net margin of -7.33%. InnovAge's return on equity of -10.00% beat Talkspace's return on equity.
12.3% of InnovAge shares are owned by institutional investors. Comparatively, 57.4% of Talkspace shares are owned by institutional investors. 0.4% of InnovAge shares are owned by insiders. Comparatively, 18.4% of Talkspace shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
InnovAge has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500. Comparatively, Talkspace has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500.
In the previous week, InnovAge had 1 more articles in the media than Talkspace. MarketBeat recorded 4 mentions for InnovAge and 3 mentions for Talkspace. Talkspace's average media sentiment score of 0.32 beat InnovAge's score of 0.31 indicating that InnovAge is being referred to more favorably in the media.
InnovAge presently has a consensus target price of $6.50, indicating a potential upside of 75.68%. Talkspace has a consensus target price of $3.00, indicating a potential upside of 9.09%. Given Talkspace's higher possible upside, research analysts clearly believe InnovAge is more favorable than Talkspace.
Talkspace has lower revenue, but higher earnings than InnovAge. Talkspace is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.
InnovAge and Talkspace both received 0 outperform votes by MarketBeat users.
Summary
InnovAge and Talkspace tied by winning 7 of the 14 factors compared between the two stocks.
Get Talkspace News Delivered to You Automatically
Sign up to receive the latest news and ratings for TALK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TALK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Talkspace Competitors List
Related Companies and Tools
